On November 1 Husky announced it has entered into a definitive agreement to acquire the Swiss group Schöttli of Diessenhofen, recognized as a global player in medical and closure mould making. The sale is expected to close in early December.
Schöttli is one of the most renowned global leader in a number of select medical applications, such as syringes, infusion/transfusion products, diagnostic systems and feminine care items. Husky hot runner customers will benefit from product improvements based on strengthened knowledge, and existing Schöttli customers will have more streamlined access to Husky's hot runner, controller and injection moulding machine products. In addition, Schöttli's closures business complements Husky's existing closures business by providing additional technology and capacity in both established and growing markets.
Besides the Swiss headquarter, also the other facilities in San Dimas (California) and Suzhou (China) will become part of Husky's global network of locations.